Home›Search›PharmacoEconomics

PharmacoEconomics

Adis International Ltd · United Kingdom · Est. 1824

ISSN1170-7690eISSN1179-2027

SJR Q1✓ WOS SCIE✓ WOS SSCI✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

148

days submission → published

measured · last 5 articles · accept 118d

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE · SSCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

1.807

H-Indexi

153

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.73

Total Worksi

4,221

Total Citationsi

150,733

2yr Mean Citednessi

2.86

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

PharmacoEconomics is the benchmark journal for peer-reviewed, authoritative articles on the practical application of health economics and outcomes research to optimize healthcare resource allocation. An essential resource for clinicians, those involved in health technology assessment and other professionals involved with healthcare resource allocation, budgeting and prescribing decisions. PharmacoEconomics is dedicated to the clear communication of complex pharmacoeconomic issues related to all healthcare interventions (drugs, diagnostics, devices, personalized medicine and surgical interventions).

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1824

FrequencyTwelve No. A Year

StatusActive (last: 2026)

Total Publications4,221

Publisher OrgAdis, Springer Healthcare

Visit Journal Website

Submission Info

Peer Reviewpeer-reviewed

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

7/12 · 58%

✅

Do you know the journal / publisher?

Adis International Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1170-7690 / 1179-2027

✅

Indexed in a trusted database?

WoS, Scopus

✅

Peer review process documented?

peer-reviewed

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

114

3.1k

2019

129

3.7k

2020

131

3.6k

2021

106

2.3k

2022

111

1.6k

2023

120

712

2024

110

252

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Health PolicyQ1

PharmacologyQ1

Public Health, Environmental and Occupational HealthQ1

Subject Classification

Web of Science Categories

EconomicsHealth Care Sciences & ServicesHealth Policy & ServicesPharmacology & Pharmacy

Scopus Categories

PharmacologyPublic Health, Environmental and Occupational HealthHealth Policy

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyHealthcare Policy and ManagementEconomic and Financial Impacts of CancerHealthcare cost, quality, practicesEconomic and Environmental ValuationGlobal Health Care IssuesPharmaceutical studies and practicesPharmaceutical industry and healthcareMedication Adherence and Compliance

Frequently asked questions about PharmacoEconomics

Is PharmacoEconomics a predatory journal?

PubScope has no integrity flags on record for PharmacoEconomics: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of PharmacoEconomics?

PharmacoEconomics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.86.

Is PharmacoEconomics indexed in Scopus and Web of Science?

PharmacoEconomics is indexed in Web of Science, Scopus.